Results 121 to 130 of about 14,283 (207)

The pathogenicity of blood stream and central nervous system forms of <i>Trypanosoma brucei rhodesiense</i> trypanosomes in laboratory mice: a comparative study. [PDF]

F1000Res, 2022
Ndungu K, Thuita J, Murilla G, Kagira J, Auma J, Mireji P, Ngae G, Okumu P, Gitonga P, Guya S, Mdachi R.   +10 more
europepmc   +1 more source

The Alkaloid-Enriched Fraction of Pachysandra terminalis (Buxaceae) Shows Prominent Activity against Trypanosoma brucei rhodesiense. [PDF]

Molecules, 2021
Flittner D, Kaiser M, Mäser P, Lopes NP, Schmidt TJ.   +4 more
europepmc   +1 more source

Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene.

, 2001
BACKGROUND: The expansion of sleeping sickness caused by Trypanosoma brucei rhodesiense beyond its traditional focus in southeast Uganda has been linked with large-scale livestock restocking.
Carrington, M, Coleman, PG, Fèvre, EM, Maudlin, I, Odiit, M, Picozzi, K, Welburn, SC   +6 more
core   +1 more source

Trypanosoma brucei rhodesiense [PDF]

, 2020
openaire   +1 more source

Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda. [PDF]

Int J Parasitol Drugs Drug Resist, 2021
Mutuku CN, Bateta R, Rono MK, Njunge JM, Awuoche EO, Ndung'u K, Mang'era CM, Akoth MO, Adung'a VO, Ondigo BN, Mireji PO.   +10 more
europepmc   +1 more source

Trypanosoma (Duttonella) vivax: Its biology, epidemiology, pathogenesis, and introduction in the New World - a review [PDF]

, 2008
The biology, epidemiology, pathogenesis, diagnostic techniques, and history of the introduction of Trypanosoma (Duttonella) vivax in the New World are reviewed.
Desquesnes, Marc, Gonçalves da Costa, Sylvio Celso, Madruga, Claudio Roberto, Osorio, Ana Luiza Alves Rosa, Ribeiro, Laura Raquel Rios, Soares, Cleber Oliveira   +5 more
core  

Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs [PDF]

, 2017
Objectives Trypanosoma brucei drug transporters include the TbAT1/P2 aminopurine transporter and the high-affinity pentamidine transporter (HAPT1), but the genetic identity of HAPT1 is unknown. We recently reported that loss of T. brucei aquaglyceroporin
Aguinaga Andrés, David, Baker, Nicola, Barrett, Michael P., Burchmore, Richard J. S., Clucas, Caroline, De Koning, Harry P., Eze, Anthonius A., Glover, Lucy, Graf, Fabrice E., Horn, David, Lee, Rebecca S., Ludin, Philipp, MacLeod, Annette, McDonald, Jennifer, Munday, Jane C., Mäser, Pascal, Natto, Manal J., Tait, Andy, Teka, Ibrahim A., Turner, C. Michael R.   +19 more
core  

Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model. [PDF]

PLoS One, 2020
Ndung'u K, Murilla GA, Thuita JK, Ngae GN, Auma JE, Gitonga PK, Thungu DK, Kurgat RK, Chemuliti JK, Mdachi RE.   +9 more
europepmc   +1 more source

Improved melarsoprol therapy for "Trypanosoma brucei rhodesiense" sleeping sickness

, 2009
Human African Trypanosomiasis (HAT) is a parasitic disease that occurs in a chronic form caused by Trypanosoma brucei gambiense in Western and Central Africa, and an acute form caused by Trypanosoma brucei rhodesiense in Eastern and Southern Africa.
openaire   +3 more sources

Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Trypanosoma brucei rhodesiense. [PDF]

ACS Med Chem Lett, 2020
Ettari R, Previti S, Di Chio C, Maiorana S, Allegra A, Schirmeister T, Zappalà M.   +6 more
europepmc   +1 more source